This often correlates with reduced caloric intake as appetite suppression takes effect
Current licensed injectable weight-management options generally work by influencing appetite and metabolic pathways linked to: feelings of fullness glucose regulation digestion speed cravings and hunger signals New investigational therapies being studied internationally act on three metabolic pathways simultaneously : GLP-1 (glucagon-like peptide-1) GIP (glucose-dependent insulinotropic polypeptide) Glucagon receptors Researchers are exploring whether this broader approach could support appetite regulation and metabolic balance in new ways
Zander, M., Madsbad, S., Madsen, J
Given retatrutide is dosed weekly, bacteriostatic water is essentially required for safe multi-week use from a single reconstitution
Phase 2 reported no increase in serious cardiovascular events
Durable responses could potentially i) improve tolerability by limiting drug exposure ii) facilitate convenient dosing schedules and increased patient adherence and iii) lead to lower long term costs on our healthcare system/payers
.png.jpg)
